These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical trials in acute decompensated heart failure--over 50 years of research. O'Connor CM; Fiuzat M Heart Fail Clin; 2011 Oct; 7(4):xv-xvii. PubMed ID: 21925426 [No Abstract] [Full Text] [Related]
3. Where have all the clinical trials gone? Francis GS J Card Fail; 2011 Sep; 17(9):701-2. PubMed ID: 21872137 [No Abstract] [Full Text] [Related]
4. End point selection in acute decompensated heart failure clinical trials: economic end points. Reed SD; Eapen ZJ; Schulman KA Heart Fail Clin; 2011 Oct; 7(4):529-37. PubMed ID: 21925436 [TBL] [Abstract][Full Text] [Related]
5. Evolving Landscape of Clinical Trials in Heart Failure: Patient Populations, Endpoint Selection, and Regions of Enrollment. Samman Tahhan A; Vaduganathan M; Greene SJ; Okafor M; Kumar S; Butler J Curr Heart Fail Rep; 2018 Feb; 15(1):10-16. PubMed ID: 29350324 [TBL] [Abstract][Full Text] [Related]
6. How can we improve clinical trials? Kaplan RS Nat Clin Pract Oncol; 2007 Apr; 4(4):206-7. PubMed ID: 17392712 [No Abstract] [Full Text] [Related]
7. Novel targets for the treatment of heart failure: perspectives from a heart failure clinician and trialist. Massie BM J Mol Cell Cardiol; 2011 Oct; 51(4):438-40. PubMed ID: 21549124 [No Abstract] [Full Text] [Related]
8. Conduct of clinical trials in acute heart failure: regional differences in heart failure clinical trials. Fiuzat M; Califf RM Heart Fail Clin; 2011 Oct; 7(4):539-44. PubMed ID: 21925437 [TBL] [Abstract][Full Text] [Related]
9. Comments on "the role of the emergency department in acute heart failure clinical trials-Enriching patient identification and enrollment" by Collins et al. Shiraishi Y; Kohsaka S; Sakai T; Harada K; Sato N; Takagi A; Miyamoto T; Fukuda K; Nagao K; Takayama M Am Heart J; 2013 Dec; 166(6):e45-6. PubMed ID: 24268223 [No Abstract] [Full Text] [Related]
11. End-point selection for acute heart failure trials. Allen LA Heart Fail Clin; 2011 Oct; 7(4):481-95. PubMed ID: 21925431 [TBL] [Abstract][Full Text] [Related]
12. Drug testing a growth industry in Salt Lake City. Brooks J CMAJ; 2000 Mar; 162(6):854, 858. PubMed ID: 10750477 [No Abstract] [Full Text] [Related]
13. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Patient selection. LVAS Study Group. Left Ventricular Assist System. Pennington DG; Griffith BP; Swartz MT; McKinlay SM; Portner PM; Domanski MJ; Watson JT ASAIO J; 1995; 41(1):23-6. PubMed ID: 7727818 [No Abstract] [Full Text] [Related]
14. Reply to letter to the editor by Shiraishi and colleagues. Collins S; Levy P; Pang P; Gheorghiade M Am Heart J; 2013 Dec; 166(6):e47. PubMed ID: 24268224 [No Abstract] [Full Text] [Related]
15. Cardiac resynchronization therapy for heart failure shows great promise. Ovsyshcher IE; Auricchio A Isr Med Assoc J; 2003 Aug; 5(8):589-91. PubMed ID: 12929300 [No Abstract] [Full Text] [Related]
16. Identifying Barriers and Practical Solutions to Conducting Site-Based Research in North America: Exploring Acute Heart Failure Trials As a Case Study. Ambrosy AP; Mentz RJ; Krishnamoorthy A; Greene SJ; Severance HW Heart Fail Clin; 2015 Oct; 11(4):581-9. PubMed ID: 26462098 [TBL] [Abstract][Full Text] [Related]
17. Unabated increases in trial costs reflect evolving research milieu. Samson K Ann Neurol; 2009 Apr; 65(4):A9-11. PubMed ID: 19399857 [No Abstract] [Full Text] [Related]
18. Current guidelines in the management of chronic heart failure: practical issues in their application to the community population. McDonald K Eur J Heart Fail; 2005 Mar; 7(3):317-21. PubMed ID: 15718171 [No Abstract] [Full Text] [Related]
19. Beta-blockers - again, a lesson to us all, especially the research funding community. Coats AJ Int J Cardiol; 2000 Apr; 73(2):103-4. PubMed ID: 10817846 [No Abstract] [Full Text] [Related]